One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial.

Zhichao LaiXin ZhangJiang ShaoKang LiLijing FangLeyin XuXiaoxi YuJingjing WangXiu LiuJinsong LeiBao Liu

Published in: BMC cardiovascular disorders (2020)

These results suggest that it is safe and effective to treat long and totally occlusive femoropopliteal artery disease with DCBs. Further studies are demanded to confirm these results.

Keyphrases

sickle cell disease
clinical trial
emergency department
phase iii
randomized controlled trial
peripheral artery disease
drug induced